Fluvastatin Sodium (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Fluvastatin Sodium drug offered from Mylan Pharmaceuticals Inc.. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: fluvastatin
SUBSTANCE NAME: FLUVASTATIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-03-19
END MARKETING DATE: 0000-00-00


Fluvastatin Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFluvastatin Sodium from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2013-03-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-8020_1c1a4abe-9621-49ae-a0e7-a35ae390532c
PRODUCT NDC: 0378-8020
APPLICATION NUMBER: ANDA090595

Other FLUVASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementFluvastatin Sodium
Mylan Pharmaceuticals Inc.Fluvastatin Sodium
Novartis Pharmaceuticals CorporationLescol
Physicians Total Care, Inc.LESCOL
Sandoz IncFLUVASTATIN SODIUM
Teva Pharmaceuticals USA, Inc.Fluvastatin